The Ohio State Wexner Medical Center
Welcome,         Profile    Billing    Logout  
 23 Trials 
23 Trials

   Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Morgenthaler, Timothy I
rēST Study, NCT03884660: remedē System Therapy Study

Recruiting
N/A
500
Europe, US
remede System
Respicardia, Inc.
Central Sleep Apnea
06/27
06/32
Crouser, Elliott D
NCT05304728: Sepsis Clinical Decision Support [CDS] Master Enrollment Study Protocol

Enrolling by invitation
N/A
40000
US
Beckman Coulter, Inc., Biomedical Advanced Research and Development Authority
Severe Sepsis, Severe Sepsis Without Septic Shock
03/25
12/26
Uribe, Alberto A
NCT04781387: Evaluation of CRS3123 vs. Oral Vancomycin in Adult Patients With Clostridioides Difficile Infection

Active, not recruiting
2
108
Canada, US
CRS3123, Active Comparator
Crestone, Inc, National Institute of Allergy and Infectious Diseases (NIAID)
Clostridioides Difficile Infection
02/24
04/24
NCT05804175: Advanced Prediction of Respiratory Depression Episode With the Linshom Continuous Predictive Respiratory Sensor

Recruiting
N/A
600
US
Linshom Continuous Predictive Respiratory Monitoring, Pulse Oximetry, Capnography
Linshom Medical, Inc., National Heart, Lung, and Blood Institute (NHLBI), Ohio State University
Post Surgical Respiratory Failure, Respiratory Complication
09/25
09/25
PDN-PM, NCT05301816: PDN Post Market, Multicenter, Prospective, Global Clinical Study

Recruiting
N/A
497
US
Spinal Cord Stimulator (SCS)
Nevro Corp
Diabetic Neuropathy, Painful
10/27
10/28
Krishna, Vibhor
LIBERATE, NCT05383872: Blood-Brain Barrier Disruption (BBBD) for Liquid Biopsy in Subjects with GlioBlastoma Brain Tumors

Recruiting
N/A
57
Canada, US
Focused Ultrasound (Exablate Model 4000)
InSightec
Glioblastoma, Glioma, Liquid Biopsy
12/24
03/25
Augostini, Ralph
Rebalance-HF, NCT04592445: Endovascular Ablation of the Right Greater Splanchnic Nerve in Subjects Having HFpEF

Recruiting
N/A
80
US
Satera GSN Ablation, Sham Control
Axon Therapies, Inc.
Heart Failure With Preserved Ejection Fraction
04/22
03/23
NCT03985527: Janus Feasibility Study

Recruiting
N/A
30
US
Transvenous nerve stimulation
Respicardia, Inc.
Sleep Apnea Syndromes
03/25
06/25
rēST Study, NCT03884660: remedē System Therapy Study

Recruiting
N/A
500
Europe, US
remede System
Respicardia, Inc.
Central Sleep Apnea
06/27
06/32
Woodburn, Erin
CELLO, NCT04877457: Ocrelizumab for Preventing Clinical Multiple Sclerosis in Individuals With Radiologically Isolated Disease.

Terminated
4
3
US
Ocrelizumab, Placebo
Yale University, Genentech, Inc.
Radiologically Isolated Syndrome, Multiple Sclerosis
06/23
06/23
MeRT-TBI-005, NCT02990793: Clinical Trial to Evaluate the Safety and Efficacy of MeRT Treatment in Post-Traumatic Stress Disorder

Recruiting
N/A
152
US
Active MeRT Treatment, rTMS Active Stimulator, Sham MeRT Treatment, rTMS Sham Stimulator
Wave Neuroscience, Texas A&M University, GilpinPhillips BIOMED, LLC, Peachtree BioResearch Solutions
PostTraumatic Stress Disorder, Traumatic Brain Injury, Postconcussive Symptoms
07/24
09/24
Brougher, Sarah
NCT03985527: Janus Feasibility Study

Recruiting
N/A
30
US
Transvenous nerve stimulation
Respicardia, Inc.
Sleep Apnea Syndromes
03/25
06/25
rēST Study, NCT03884660: remedē System Therapy Study

Recruiting
N/A
500
Europe, US
remede System
Respicardia, Inc.
Central Sleep Apnea
06/27
06/32
Sevensma, Matthew
rēST Study, NCT03884660: remedē System Therapy Study

Recruiting
N/A
500
Europe, US
remede System
Respicardia, Inc.
Central Sleep Apnea
06/27
06/32
Karl, Cindy
CAPTIVA, NCT05047172: Comparison of Anti-coagulation and Anti-Platelet Therapies for Intracranial Vascular Atherostenosis

Recruiting
3
1683
US
Ticagrelor + Aspirin, Brilinta, Rivaroxaban + Aspirin, Xarelto, Clopidogrel + Aspirin, Plavix, Risk Factor Management
University of Florida, National Institute of Neurological Disorders and Stroke (NINDS), University of Cincinnati, Medical University of South Carolina, Janssen Scientific Affairs, LLC, AstraZeneca
Intracranial Arteriosclerosis, Stroke
05/28
05/28
RESTORE, NCT04451525: REal-World Analyses of Stroke - Thrombus Occlusion REtrieval

Recruiting
N/A
1000
US
MicroVention Mechanical Thrombectomy Devices as first-line treatment
Microvention-Terumo, Inc.
Acute Ischemic Stroke, Vessel Occlusion, Stroke, Ischemic
12/25
12/25
rēST Study, NCT03884660: remedē System Therapy Study

Recruiting
N/A
500
Europe, US
remede System
Respicardia, Inc.
Central Sleep Apnea
06/27
06/32
Adjei-Poku, Yaw
NCT06292013: A Study to Investigate the Effect of Lepodisiran on the Reduction of Major Adverse Cardiovascular Events in Adults With Elevated Lipoprotein(a) - ACCLAIM-Lp(a)

Recruiting
3
12500
Europe, Canada, Japan, US, RoW
Lepodisiran Sodium, LY3819469, Placebo
Eli Lilly and Company
Atherosclerotic Cardiovascular Disease (ASCVD), Elevated Lp(a)
03/29
03/29
ACHIEVE-4, NCT05803421: A Study of Daily Oral Orforglipron (LY3502970) Compared With Insulin Glargine in Participants With Type 2 Diabetes and Obesity or Overweight at Increased Cardiovascular Risk

Active, not recruiting
3
2749
Europe, US, RoW
Orforglipron, LY3502970, Insulin Glargine
Eli Lilly and Company
Type 2 Diabetes, Obesity, Overweight or Obesity, Overweight, Cardiovascular Diseases, Chronic Kidney Disease
09/25
01/26
ATTAIN-2, NCT05872620: A Study of Orforglipron in Adult Participants With Obesity or Overweight and Type 2 Diabetes

Active, not recruiting
3
1500
Europe, US, RoW
Orforglipron, LY3502970, Placebo
Eli Lilly and Company
Obesity, Overweight, Type 2 Diabetes
08/25
08/25
SURMOUNT-MMO, NCT05556512: A Study of Tirzepatide (LY3298176) on the Reduction on Morbidity and Mortality in Adults With Obesity

Active, not recruiting
3
15374
Europe, Canada, Japan, US, RoW
Tirzepatide, LY3298176, Placebo
Eli Lilly and Company
Obesity, Overweight
10/27
10/27
rēST Study, NCT03884660: remedē System Therapy Study

Recruiting
N/A
500
Europe, US
remede System
Respicardia, Inc.
Central Sleep Apnea
06/27
06/32
Nascak, Sam
rēST Study, NCT03884660: remedē System Therapy Study

Recruiting
N/A
500
Europe, US
remede System
Respicardia, Inc.
Central Sleep Apnea
06/27
06/32

Download Options